Borlaug BA, Sharma K, Shah SJ, Ho JE (2023) Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol 81:1810–1834. https://doi.org/10.1016/j.jacc.2023.01.049

Article  PubMed  Google Scholar 

Roh J, Hill JA, Singh A, Valero-Muñoz M, Sam F (2022) Heart failure with preserved ejection fraction: heterogeneous syndrome, diverse preclinical models. Circ Res 130:1906–1925. https://doi.org/10.1161/CIRCRESAHA.122.320257

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14:591–602. https://doi.org/10.1038/nrcardio.2017.65

Article  PubMed  Google Scholar 

Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R, Chirinos JA, Collins S, Deo RC, Gladwin MT, Granzier H, Hummel SL, Kass DA, Redfield MM, Sam F, Wang TJ, Desvigne-Nickens P, Adhikari BB (2020) Research priorities for heart failure with preserved ejection fraction: national heart, lung, and blood institute working group summary. Circulation 141:1001–1026. https://doi.org/10.1161/CIRCULATIONAHA.119.041886

Article  PubMed  PubMed Central  Google Scholar 

Borlaug BA, Redfield MM (2011) Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123:2006–2014. https://doi.org/10.1161/CIRCULATIONAHA.110.954388

Article  PubMed  PubMed Central  Google Scholar 

Figtree GA, Rådholm K, Barrett TD, Perkovic V, Mahaffey KW, De Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B (2019) Effects of canagliflozin on heart failure outcomes associated with preserved and reduced ejection fraction in type 2 diabetes mellitus: results from the CANVAS program. Circulation 139:2591–2593. https://doi.org/10.1161/CIRCULATIONAHA.119.040057

Article  PubMed  Google Scholar 

Dyck JRB, Sossalla S, Hamdani N, Coronel R, Weber NC, Light PE, Zuurbier CJ (2022) Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects. J Mol Cell Cardiol 167:17–31. https://doi.org/10.1016/j.yjmcc.2022.03.005

Article  PubMed  CAS  Google Scholar 

Capone F, Nambiar N, Schiattarella GG (2024) Beyond weight loss: the emerging role of incretin-based treatments in cardiometabolic HFpEF. Curr Opin Cardiol. https://doi.org/10.1097/HCO.0000000000001117

Article  PubMed  Google Scholar 

Borlaug BA (2020) Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 17:559–573. https://doi.org/10.1038/s41569-020-0363-2

Article  PubMed  CAS  Google Scholar 

Schiattarella GG, Hill JA (2021) Cardiometabolic HFpEF: mechanisms and therapies. Cardiometab Syndr J 1:117. https://doi.org/10.51789/cmsj.2021.1.e18

Article  Google Scholar 

Lobstein T, Jackson-Leach R, Powis J, Brinsden H, Gray M (2023) World Obesity Atlas 2023. https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023

Guo L, Liu X, Yu P, Zhu W (2022) The “obesity paradox” in patients with HFpEF with or without comorbid atrial fibrillation. Front Cardiovasc Med 8:743327. https://doi.org/10.3389/fcvm.2021.743327

Article  PubMed  PubMed Central  Google Scholar 

Haass M, Kitzman DW, Anand IS, Miller A, Zile MR, Massie BM, Carson PE (2011) Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circ: Heart Failure 4:324–331. https://doi.org/10.1161/CIRCHEARTFAILURE.110.959890

Schiattarella GG, Alcaide P, Condorelli G, Gillette TG, Heymans S, Jones EAV, Kallikourdis M, Lichtman A, Marelli-Berg F, Shah SJ, Thorp EB, Hill JA (2022) Immunometabolic mechanisms of heart failure with preserved ejection fraction. Nat Cardiovasc Res 1:211–222. https://doi.org/10.1038/s44161-022-00032-w

Article  PubMed  PubMed Central  Google Scholar 

Shah MS, Brownlee M (2016) Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res 118:1808–1829. https://doi.org/10.1161/CIRCRESAHA.116.306923

Article  PubMed  PubMed Central  CAS  Google Scholar 

Carbone S, Mauro AG, Mezzaroma E, Kraskauskas D, Marchetti C, Buzzetti R, Van Tassell BW, Abbate A, Toldo S (2015) A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice. Int J Cardiol 198:66–69. https://doi.org/10.1016/j.ijcard.2015.06.136

Article  PubMed  Google Scholar 

La Gerche A, Howden EJ, Haykowsky MJ, Lewis GD, Levine BD, Kovacic JC (2022) Heart failure with preserved ejection fraction as an exercise deficiency syndrome. J Am Coll Cardiol 80:1177–1191. https://doi.org/10.1016/j.jacc.2022.07.011

Article  PubMed  Google Scholar 

Capone F, Sotomayor-Flores C, Bode D, Wang R, Rodolico D, Strocchi S, Schiattarella GG (2023) Cardiac metabolism in HFpEF: from fuel to signalling. Cardiovasc Res 118:3556–3575. https://doi.org/10.1093/cvr/cvac166

Article  PubMed  CAS  Google Scholar 

American Heart Association Life’s Simple 7® Journey to HealthTM. https://www.heart.org/-/media/files/professional/workplace-health/detailed-overview-whs-with-ls7-journey-1218.pdf?la=en&hash=9D16F77814743A12695010D025065588CD1F9A44

Aggarwal M, Bozkurt B, Panjrath G, Aggarwal B, Ostfeld RJ, Barnard ND, Gaggin H, Freeman AM, Allen K, Madan S, Massera D, Litwin SE (2018) Lifestyle modifications for preventing and treating heart failure. J Am Coll Cardiol 72:2391–2405. https://doi.org/10.1016/j.jacc.2018.08.2160

Article  PubMed  Google Scholar 

Bohmke NJ, Billingsley HE, Kirkman DL, Carbone S (2022) Nonpharmacological strategies in heart failure with preserved ejection fraction. Cardiol Clin 40:491–506. https://doi.org/10.1016/j.ccl.2022.06.003

Article  PubMed  PubMed Central  Google Scholar 

Larsson SC, Tektonidis TG, Gigante B, Åkesson A, Wolk A (2016) Healthy lifestyle and risk of heart failure: results from 2 prospective cohort studies. Circ: Heart Failure 9:e002855. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002855

Lara KM, Levitan EB, Gutierrez OM, Shikany JM, Safford MM, Judd SE, Rosenson RS (2019) Dietary patterns and incident heart failure in U.S. adults without known coronary disease. J Am Coll Cardiol 73:2036–2045. https://doi.org/10.1016/j.jacc.2019.01.067

Article  PubMed  PubMed Central  Google Scholar 

Folsom AR, Shah AM, Lutsey PL, Roetker NS, Alonso A, Avery CL, Miedema MD, Konety S, Chang PP, Solomon SD (2015) American Heart Association’s Life’s Simple 7: avoiding heart failure and preserving cardiac structure and function. Am J Med 128:970-976.e2. https://doi.org/10.1016/j.amjmed.2015.03.027

Article  PubMed  PubMed Central  Google Scholar 

Carbone S, Canada JM, Buckley LF, Trankle CR, Dixon DL, Buzzetti R, Arena R, Van Tassell BW, Abbate A (2016) Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 68:2487–2488. https://doi.org/10.1016/j.jacc.2016.08.072

Article  PubMed  PubMed Central  Google Scholar 

Levitan EB, Lewis CE, Tinker LF, Eaton CB, Ahmed A, Manson JE, Snetselaar LG, Martin LW, Trevisan M, Howard BV, Shikany JM (2013) Mediterranean and DASH diet scores and mortality in women with heart failure: the women’s health initiative. Circ: Heart Failure 6:1116–1123. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000495

Carbone S, Canada JM, Buckley LF, Trankle CR, Billingsley HE, Dixon DL, Mauro AG, Dessie S, Kadariya D, Mezzaroma E, Buzzetti R, Arena R, Van Tassell BW, Toldo S, Abbate A (2017) Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction. JACC: Basic to Translational Science 2:513–525. https://doi.org/10.1016/j.jacbts.2017.06.009

Kim MY, Pellot I, Bresee C, Nawaz A, Fournier M, Cho JH, Cingolani E (2023) Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction. J Molec Cell Cardiol Plus 3:100031. https://doi.org/10.1016/j.jmccpl.2023.100031

Article  Google Scholar 

Shah SJ (2017) Sedentary lifestyle and the risk for HFpEF. J Am Coll Cardiol 69:1143–1146. https://doi.org/10.1016/j.jacc.2017.01.010

Article  PubMed  Google Scholar 

McGee SL, Hargreaves M (2020) Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit. Nat Rev Endocrinol 16:495–505. https://doi.org/10.1038/s41574-020-0377-1

Article  PubMed  CAS  Google Scholar 

Fiuza-Luces C, Santos-Lozano A, Joyner M, Carrera-Bastos P, Picazo O, Zugaza JL, Izquierdo M, Ruilope LM, Lucia A (2018) Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors. Nat Rev Cardiol 15:731–743. https://doi.org/10.1038/s41569-018-0065-1

Article  PubMed  CAS  Google Scholar 

Nayor M, Shah RV, Miller PE, Blodgett JB, Tanguay M, Pico AR, Murthy VL, Malhotra R, Houstis NE, Deik A, Pierce KA, Bullock K, Dailey L, Velagaleti RS, Moore SA, Ho JE, Baggish AL, Clish CB, Larson MG, Vasan RS, Lewis GD (2020) Metabolic architecture of acute exercise response in middle-aged adults in the community. Circulation 142:1905–1924. https://doi.org/10.1161/CIRCULATIONAHA.120.050281

Article  PubMed